Dodecylmaltoside modulates bi-cellular tight junction contacts to

Subscriber access provided by UNIVERSITY OF ADELAIDE LIBRARIES

Brief Article

Dodecylmaltoside modulates bi-cellular tight junction contacts to promote enhanced permeability K. Gradauer, M. Iida, A. Watari, M. Kataoka, S. Yamashita, M. Kondoh, and S.T. Buckley Mol. Pharmaceutics, Just Accepted Manuscript • DOI: 10.1021/acs.molpharmaceut.7b00297 • Publication Date (Web): 06 Oct 2017 Downloaded from http://pubs.acs.org on October 9, 2017

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Molecular Pharmaceutics is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 25

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

Dodecylmaltoside modulates bi-cellular tight junction contacts to promote enhanced permeability Gradauer K 1,2, Iida M 3, Watari A 3, Kataoka M 2, Yamashita S 2, Kondoh M 3, Buckley ST 1

1

Global Research, Novo Nordisk A/S, Måløv, Denmark

2

Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan

3 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan

* Corresponding author: Stephen T. Buckley, Ph.D. Global Research, Novo Nordisk A/S, Novo Nordisk Park DK-2760 Måløv, Denmark Tel: +45 3079 4609 e-mail: [email protected]

1

ACS Paragon Plus Environment


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 25

Abstract Intestinal permeation enhancers are a crucial component of many oral formulations, without which many drugs would show an insufficient absorption in the gut. The present study sought to provide a better understanding of the molecular interaction of such absorption enhancers with the intestine, by investigating the effect of the surfactant – like permeation enhancer dodecylmaltoside (DDM) on Caco-2 cells. The extent to which the action of DDM is apportioned between the para- and transcellular routes was addressed by examining the transport of relevant marker compounds ([3H]mannitol and [3H]-propranolol, respectively). In the case of [3H]-mannitol, a robust permeation enhancement was achieved with 0.5 mM DDM (~6-fold), whereas little effect was seen on the permeation of [3H]-propranolol. Concomitantly measured TEER values revealed a rapid onset of action of DDM with a swift recovery and complete restitution (> 90%) within 4 hours after washout. To localise the site(s) of action of DDM at the absorptive surface of Caco-2 cells, sulfo-NHSSS-biotin, a membrane-impermeable compound, was applied apically. In the presence of 0.5 mM DDM, translocated biotin was found to be accumulated towards bicellular contacts, whereas no biotin permeation was observed in untreated control cells. Western blot analysis of DDM-treated and untreated Caco-2 cells revealed an interaction of DDM with specific tight junction-associated proteins, resulting in a reduction of claudins -3 and -4 and also occludin, as well as a depletion of claudin-2 from lipid rafts. Collectively, the results presented provide a more in depth understanding of the molecular mechanism(s) underlying the permeation-enhancing actions of DDM.

2


Page 3 of 25

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Graphical abstract

Keywords: maltoside, permeation enhancement, tight junctions, claudins, lipid rafts,

3



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 25

Introduction The gastrointestinal (GI) barrier is comprised of a network of epithelial cells interconnected by tight junctions, which severely hinders the uptake of drugs, and in particular, that of large, hydrophilic ones (e.g., peptides and proteins). Thus, to effectively overcome these impediments and thereby achieve acceptable bioavailability upon oral administration, employment of an absorption enhancer is often necessary 1. The manner by which increased absorption of an orally-delivered peptide is achieved is governed to a great extent by the behaviour and mechanism of action of the coformulated absorption enhancer. A large proportion of the intestinal permeation enhancers reported in the literature, exhibit surfactants(-like) properties 1,2. On account of this physicochemical trait, many have been reported to enhance permeation via membrane perturbation 3,4. However, especially at lower concentrations, some have been observed to increase permeability primarily through paracellular pathways 5,6. One such example that has been employed in a number of peptide formulations, are maltosides, a family of non-ionic surfactants 7. Although several studies point towards paracellular permeation enhancement as the predominate mechanism underlying the effect of maltosides 4,8, there still remains a dearth of information pertaining to the precise mode of action, and in particular, the manner in which they interact with tight junctions Paracellular permeability is regulated by a junctional complex located in the apicolateral membrane of epithelial cells, termed tight junctions (TJs) 9. They consist of transmembrane proteins; e.g. claudins (CL), occludin (OCLN) and junctional adhesion molecules (JAMs); and peripheral proteins; e.g., zonula occludens proteins (ZO). Even though the knockout of specific claudins leads to a loss of barrier function

10

, claudins are not the only structural component important for TJ

integrity. In fact, rather than solely focusing on the protein element of TJs, several groups have been investigating the role of the lipid bilayer itself on the function of TJs 11,12. Nusrat et al. were the first

4


Page 5 of 25

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


to demonstrate a co-localisation of TJ-associated proteins with cholesterol- and glycolipid-rich, detergent-resistant membrane domains, termed lipid rafts 13. Later, it was observed that a disruption of such lipid rafts invoked the loss of barrier function 14,15. Following this path, recent studies have investigated the effect of the permeation enhancers sodium caprate (C10) and alkyarnitines on the distribution of TJ-associated proteins within the cell membrane

16,17

. However, the number of

studies investigating this hypothetical mode of action remains relatively limited. The present work sought to provide a deeper mechanistic understanding of the molecular events, which drive and direct the permeation enhancing effects of dodecylmaltoside (DDM), and thereby clarify to what extent lipid rafts might be involved. The extent to which the action of DDM is apportioned between the para- and transcellular routes was also addressed by examining the transport of relevant marker compounds ([3H]-mannitol and [3H]-propranolol, respectively) in Caco-2 cells, together with monitoring of alterations in barrier properties via transepithelial electrical resistance (TEER) measurements and the subsequent rate of recovery. In addition, visualisation of the nature of the effect of DDM on the intestinal epithelial barrier was performed using confocal laser scanning microscopy (CLSM), whereby the translocation of a hydrophilic, cell membrane impermeable compound, sulfo-NHS-SS-biotin, was investigated. Moreover, the effect of DDM on the integrity of TJ-associated proteins was investigated, as well as its impact on their distribution between cholesterol-rich lipid rafts and non-raft regions of the membrane.

5



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 6 of 25

Materials and Methods

Materials Rabbit anti-CL-1 polyclonal antibody (pAb), mouse anti-CL-2 monoclonal antibody (mAb), rabbit anti-CL-3 pAb, mouse anti-CL-4 mAb, mouse anti-OCLN mAb and rabbit anti-ZO-1 pAb were purchased from Invitrogen (Carlsbad, CA, USA). Mouse anti-E-cadherin mAb and mouse anti-βactin mAb were purchased from BD Biosciences (Franklin Lakes, NJ, USA) and Sigma-Aldrich (St. Louis, MO, USA), respectively. Goat anti-Rabbit IgG peroxidase-conjugated antibody and goat anti-mouse IgG peroxidase-conjugated antibody were purchased from Millipore (Bedford, MA, USA). Sulfosuccinimidyl-2-[biotinamido]-ethyl-1,3-dithiopropionate (sulfo-NHS-SS-biotin) and alexa-555 conjugated streptavidine were purchased from Thermo Fisher Scientific (Waltham, MA, USA). FITC- conjugated anti-rabbit IgG antibody (Thermo Fisher Scientific), 4',6-diamidino-2phenylindole (DAPI) (Sigma-Aldrich), N-dodecyl-β-D-maltopyranoside (dodecylmaltoside, DDM) was purchased from Affymetrix (Santa Clara, CA, USA). All other reagents used were of the highest purity available (95% or higher).

Caco-2 cell culture Caco-2 cells were cultured in DMEM supplemented with 10% (v/v) FBS, 1% (v/v) non-essential amino acids, and 0.5% (v/v) antibiotic–antimycotic mixture in a flask of adequate volume (Nippon Becton Dickinson, Tokyo, Japan) at 95% humidity and 37 °C in a 95% air/ 5% CO2 atmosphere. Cells (passages 47-60) were harvested using trypsin–EDTA and seeded on cell culture inserts with a polyethylene terephthalate membrane (1.13 cm2 growth area for permeation studies; 4.2 cm2 growth area for western blotting and the biotin assay). The medium was changed every 48 hours for 14–21 days and trans epithelial electrical resistance (TEER) was measured with a chopstick electrode

6


Page 7 of 25

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


(Millicell-ERS, Millipore, Billerica, MA) prior to testing and monolayers 90%) being achieved within 2 and 4 hours following exposure to 0.16 and 0.5 mM DDM, respectively. Plotting the Papp of [3H]-mannitol versus the membrane conductance (Gt) revealed a strong linear relationship (r2=0.96) (Figure 1F).

Biotin assay

11



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 12 of 25

To provide further insight into specific facets of the molecular mechanism(s) underpinning the permeation enhancing effect of DDM, sulfo-NHS-SS-biotin, a membrane-impermeable compound, was applied apically to localise the site(s) of action of DDM at the absorptive surface of Caco-2 cells. Following application and subsequent washing, translocated biotin (red; Fig. 2) was found to be accumulated towards bicellular contacts (green; Fig. 2) as revealed by co-localisation of both signals in the lateral (z-) axis scan of the cell monolayer. In contrast, no biotin permeation was observed in untreated control cells.

Effect of DDM on the integrity and distribution of tight junction-associated proteins To investigate the effect of DDM on the integrity and distribution of CL-1, -2, -3, 4, OCLN and ECad, Caco-2 cells were incubated for 2 hours with either 0.16 or 0.5 mM DDM or in the absence of DDM to serve as a control (Fig.3). Examining expression levels in the soluble and insoluble fractions, clear differences were observed between the different proteins. When compared with untreated cells, CL-1 and E-Cad did not show any difference in their distribution following exposure to 0.16 or 0.5 mM DDM. In contrast, the amount of CL-4 and OCLN was decreased in both the soluble and insoluble fraction, and also in the whole cell lysate, after incubation with 0.5 mM DDM. The pattern of distribution of CL-2 and -3 revealed a reduction in the insoluble fraction upon incubation with DDM. However, although the amount in the soluble fraction increased for CL-2, it remained unchanged for CL-3. Furthermore, differences were also observed for these two claudins in the whole cell lysate whereby DDM gave rise to a reduction in the amount of CL-3, while CL-2 levels remained unaffected.

12


Page 13 of 25

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Discussion The aim of the present study was to expand the molecular understanding of the mode of action of maltosides as it relates to their action as intestinal permeation enhancers. DDM concentrations of 0.16 mM and 0.5 mM were used throughout, whereby 0.16 mM corresponded to a concentration just below the reported critical micelle concentration (CMC) of 0.18 mM. While the lower concentration provided a mild enhancing effect on [3H]-mannitol permeation, the higher concentration of 0.5 mM elicited a much more pronounced effect (Fig. 1). In contrast to the paracellular marker, [3H]-mannitol, only a very slight permeation enhancement effect was observed for the transcellular marker, [3H]-propranolol. This lack of transcellular permeation enhancement as well the transient effect on TEER upon exposure and subsequent removal of DDM, strongly support the notion of a predominantly paracellular permeation enhancement effect. Consistent with our findings, a number of other groups investigating the effect of maltosides on various cell lines report primarily paracellular effects 8,19,20. However, maltosides should not be considered as one homogenous group as it relates to their permeation enhancing properties. Eley et al. compared in their work 13 alkylglycosides with different chain lengths and carbohydrate moieties and found that they differ significantly in their impact on tight junctions and cell integrity. DDM and octylglucoside were the only two showing activity at low concentrations, a rapid onset of their permeation enhancement and a short cell recovery time, indicating a negligible disruption of cell membranes and a mainly paracellular permeation enhancement effect 4. To investigate the impact of DDM on the permeation of macromolecules, sulfo-NHS-SS-biotin was used as a model compound. Adding it to the apical side of Caco-2 monolayers in presence of DDM clearly demonstrated the presence of sulfo-NHS-SS-biotin within the paracellular space. This provides visualise evidence to support the paracellular-mediated permeation enhancing effect of

13



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 14 of 25

DDM. Moreover, it identified the bicellular junctions as its primary target. Intriguingly, this finding differs from that reported in analogous studies with other intestinal permeation enhancers. Sodium caprate (C10), for example, is a medium chain fatty acid, which is has previously been marketed in a rectal suppository in Sweden and Japan 21 and is currently in clinical trials as a component of oral peptide formulations 22. In contrast to DDM, C10 induced the translocation of sulfo-NHS-SS-biotin through tricellular tight junctions by removing tricellulin from tight junctions 18. Interestingly, sodium laurate (C12), which differs in structure to sodium caprate by just two carbon atoms, is reported to exhibit a distinctly different effect as it relates to drug permeation. Studies carried out in the intestinal epithelial cell model HT-29/B6 revealed an enhanced paracellular permeation of fluorescein (330 Da) while permeabilities for FITC-dextran (4 kDa) and sulpho-NHS-SS-biotin (607 Da) remained unaltered 23. These results highlight the complexity of the mechanisms of intestinal permeation enhancement and emphasise the importance of differentiating between individual compounds, despite apparent structural similarities. For a deeper insight into the mechanism by which DDM increases paracellular drug absorption, both concentrations were employed in investigations to examine their impact on tight junction associated proteins and on E-Cadherin, a protein associated with adherens junctions 24. To investigate the distribution of those proteins within the plasma membrane, cells were solubilised using Triton X-100 to separate lipid rafts from other parts of the cell followed by an analysis of the proteins in both fractions. The results observed indicate different effects of DDM on different TJassociated proteins (Fig.3). While no effect was seen on CL-1 and E-Cad, different effects were seen for CL-2, -3, 4 and OLCN. This apparent selectivity was not entirely unexpected and is consistent with that reported for other molecules 25–28. Similar to DDM, C10 for example, showed a predominant effect on CL-4, -5 and OCLN 16. However, while C10 seemed to only change the protein distribution from the insoluble to the soluble fraction, DDM lowered the protein content in

14


Page 15 of 25

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


both fractions, as well as in the whole cell lysate. A similar observation was made by Doi et al.27, who found that palmitoylcarnitine reduced the protein levels of CL-1,-4 and -5 in Caco-2 monolayers, which was attributed to cholesterol leakage from the cell membrane into the apical media. In addition, it was shown that the reductions of CL-4 protein level were restored after removal of palmitoylcarnitine. Given that DDM is a surfactant, and thus likely to interact with the membrane, a similar mechanism might underlie the permeation enhancing effect of DDM. Disrupting the lipid rafts in the membrane might lead to a delocalisation of specific TJ-associated proteins from lipid rafts followed by internalisation and degradation of TJ-associated proteins triggered by the change in phospholipid composition surrounding the protein

11

. In the case of CL-2

the protein seemed to be only delocalised from the lipid rafts, but without any subsequent degradation. Another observation reported for several permeation enhancers, including maltosides, is a differential permeation enhancing effect depending on the region of the intestine 8,29. In a previous study carried out in our lab, DDM demonstrated a pronounced permeation enhancement for FD4 in colonic but not jejunal in situ instillation studies in rats 30. Knowing now that DDM interacts with CL-2, -3, -4 and OCLN, it could be hypothesised, as to whether differences in the expression of tight junction associated proteins in different segments of the intestine could be the reason for this observation. Although earlier studies did not find differences in the expression pattern of TJ proteins 31, more recent studies contradict this. For example, Markov et al. found a much higher expression of “tightening” claudins, namely CL-1, -3, -4, -5 and -8 in the colonic- than in the small intestinal tissue of rats 32, and Lameris et al. investigated the expression of different claudins in human intestinal tissue, reporting an increase in CL-3, -4, -7 and -8 from proximal to distal areas 33.

15



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 16 of 25

Summarising the results from the present study, we were able to provide a more detailed picture of the permeation enhancing mechanism of dodecylmaltoside. DDM induced a rapid and reversible decrease in TEER, and an enhanced permeation of the paracellular marker [3H]-mannitol via opening of tight junctions. Moreover, it promoted the paracellular passage of the hydrophilic macromolecule, sulfo-NHS-SS-biotin, which was shown to permeate through bicellular tight junctions. These effects were found to be attributed to the interaction of DDM with specific tight junction-associated proteins, resulting in a reduction of the tightening claudins -3 and -4 and also occludin, as well as a depletion of claudin-2 from lipid rafts. Even though tight junctions are highly complex structures and the effect of permeation enhancers on TJ-associated proteins is difficult to predict, the present study provides a further step towards a better understanding of the molecular mechanism(s), of DDM, and potentially to some extent that of other maltosides and related non-ionic surfactants.

16


Page 17 of 25

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Figures Fig. 1. Effect of dodecylmaltoside (DDM) on Caco-2 cells. A. Transepithelial resistance (TEER) of

Caco-2 cells during a 2 h incubation with 0.16 mM (▲) or 0.5 mM () DDM and cell recovery following a washout and 24 h incubation in cell culture media. DDM treated cells were compared to a control treated the same way but in the absence of DDM (dashed line). B, C and D, E. Permeation profiles and apparent permeability coefficients (Papp) of a paracellular- and a transcellular marker; [3H]-mannitol and [3H]-propranolol, respectively; in the presence and absence of DDM. Basolateral concentrations of both marker compounds were monitored for 120 minutes and used to calculate apparent permeability coefficients (Papp). F. Relationship between Papp ([3H]-mannitol) and membrane conductance (Gt). Indicated values are the means ± SD of four experiments (# p

Dodecylmaltoside modulates bi-cellular tight junction contacts to

Recommend Documents